Federal health officials are moving fast to let AI diagnose and treat patients, but is the technology ready? In this episode of Doctors Take the Mic, Dr. Wu looks at Christina Jewett's New York Times report "U.S. Health Officials Move Quickly to Deploy Medical A.I. Despite Concerns." It was published online September 14, 2026, and ran in print September 16 under the headline "Dr. A.I. Will See You, Despite Misgivings." The story follows Curai Health, the company run by Neal Khosla, son of billionaire venture capitalist Vinod Khosla, as federal health officials consider AI models that can diagnose and even prescribe. Clinicians agreed with Curai's AI about 91% of the time across roughly 2,300 cases. But in three of those cases, the AI suggested a telehealth visit where a human doctor would have sent the patient for urgent or emergency care. Dr. Wu explains why that gap matters: AI can pass the medical boards, but it can't yet see a patient turning blue. She also covers Limbic, a mental health AI led by CEO Ross Harper, which outperformed human therapists in a study published in Nature Medicine. That result raises hard questions about how AI should handle patients at risk of suicide. The episode ends at the FDA, where Jared Seehafer, a former tech founder, is now Deputy Commissioner for Technology and AI, and with Dr. Wu's case for why physicians need a seat at the table as these decisions get made.